We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · April 29, 2021

Outcomes After DAA Therapy in HCV-Related Cirrhosis Depend on Disease Severity

Journal of Hepatology


Additional Info

Journal of Hepatology
Clinical Outcomes Following DAA Therapy in Patients With HCV-Related Cirrhosis Depend on Disease Severity
J. Hepatol. 2021 May 01;74(5)1053-1063, LAP Krassenburg, R Maan, A Ramji, MP Manns, M Cornberg, H Wedemeyer, RJ de Knegt, BE Hansen, HLA Janssen, RA de Man, JJ Feld, AJ van der Meer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading